TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33494843

Group type: EXPERIMENTAL
Intervention: Sodium intake assessment via 24-hour urine collection
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Potassium intake assessment via 24-hour urine collection
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: High sodium intake
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Low potassium intake
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Association of Na and K excretion with BMI and age
Number of subjects: 479
Study: 32821503

Group type: EXPERIMENTAL
Intervention: Biofeedback rehabilitation (BF)
Number of subjects: 24
Study: 35278847

Group type: EXPERIMENTAL
Intervention: CRS education with biomechanical visualization
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CRS education with behavioral skill training
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CRS education‐only
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study: 33387108

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with MMC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ahmed valve
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ex‐Press Minishunt with MMC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diode cyclophotocoagulation
Number of subjects: 40
Study: 34702183

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane block (ESPB) with 40 ml of 0.5% Ropivacaine, divided into two equal volumes, injected at T8 level under ultrasound guidance.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wound infiltration (WI) with a 40 ml bolus of 0.5% Ropivacaine infiltrated at the ports and minimally invasive wound.
Number of subjects: 72
Study: 33219392

Group type: EXPERIMENTAL
Intervention: Low-glycemic load (LGL) diet for 28 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: High glycemic load (HGL) diet for 28 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clinical lipid panel measures (total-, VLDL-, LDL-, HDL-cholesterol and triglycerides)
Number of subjects: 80
Study: 36280027

Group type: EXPERIMENTAL
Intervention: S-ketamine plus propofol, cisatracurium, and sufentanil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline plus propofol, cisatracurium, and sufentanil
Number of subjects: 100
Study: 33896234

Group type: EXPERIMENTAL
Intervention: Interferential current plus photobiomodulation
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168

Group type: COMPARATOR
Intervention: Interferential current
Number of subjects: 168
Study: 35841422

Group type: EXPERIMENTAL
Intervention: LB-102 (50, 100, 200, 400 mg single ascending dose; 150 mg/day multiple ascending dose)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: LB-102 (200 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: LB-102 (100 mg QD, 75 mg BID, 100 mg BID)
Number of subjects: 64
Study: 34023695

Group type: EXPERIMENTAL
Intervention: Facilitated subcutaneous immunoglobulin therapy (fSCIG)
Number of subjects: 12
Study: 35687377

Group type: EXPERIMENTAL
Intervention: 27 mg/day elemental iron supplementation as part of a prenatal multivitamin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ethnicity as a modifier
Number of subjects: 60
Study: 32712847

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide dressing applied after 3 weeks of exposure to POS (blood)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide dressing applied after 3 weeks of exposure to LED (Ledermix)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group NEG (empty)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group ODO (Odontopaste)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Final restoration after Ca(OH)2 dressing
Number of subjects: 80
Study: 32533948

Group type: EXPERIMENTAL
Intervention: Convolutional neural network applied to corneal topography raw data
Number of subjects: 3000
Study: 36415169

Group type: EXPERIMENTAL
Intervention: Angled tip guidewire
Number of subjects: 422

Group type: COMPARATOR
Intervention: Straight tip guidewire
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Angled tip guidewire for intrahepatic stricture
Number of subjects: 422

Group type: COMPARATOR
Intervention: Straight tip guidewire for intrahepatic stricture
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Both guidewires (standard vs. enhanced flexibility)
Number of subjects: 422
Study: 33214082

Group type: EXPERIMENTAL
Intervention: Liposomal irinotecan + 5 FU/LV with dose modification (n=53)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Liposomal irinotecan + 5 FU/LV without dose modification (n=40)
Number of subjects: 93
Study: 32092636

Group type: EXPERIMENTAL
Intervention: Current cannabis use
Number of subjects: 207
Study: 35861647

Group type: EXPERIMENTAL
Intervention: ECochG 'on' during CI surgery
Number of subjects: 85

Group type: COMPARATOR
Intervention: ECochG 'off' during CI surgery
Number of subjects: 85
Study: 33957657

Group type: EXPERIMENTAL
Intervention: High-dose oxytocin (6 milliunits/min)
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Standard-dose oxytocin (2 milliunits/min)
Number of subjects: 1003
Study: 32790783

Group type: EXPERIMENTAL
Intervention: Caregiver responsive behaviours score
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Child responsive behaviours score
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Caregiver-child interaction score
Number of subjects: 857
Study: 35668461

Group type: EXPERIMENTAL
Intervention: Interrupted suture technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Continuous suture technique
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 100
Study: 35773147

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE)
Number of subjects: 8179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8179
Study: 34508116

Group type: EXPERIMENTAL
Intervention: BeBo Concept exercise program (6-week physical therapy)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 56
Study: 36153027

Group type: EXPERIMENTAL
Intervention: Mobile health app providing digitalised home exercises (Virtual Training app)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Supervised exercise therapy (standard treatment, 2 weekly sessions)
Number of subjects: 156
Study: 36140045

Group type: EXPERIMENTAL
Intervention: FM-SRP with Azithromycin (AZM)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (supragingival calculus removal and oral hygiene instructions)
Number of subjects: 51
Study: 33177133

Group type: EXPERIMENTAL
Intervention: Creative Expressive Arts-based Storytelling (CrEAS) programme
Number of subjects: 111

Group type: COMPARATOR
Intervention: Recreation group
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual activity group
Number of subjects: 111
Study: 32171511

Group type: EXPERIMENTAL
Intervention: Enzyme-treated soybean meal (ESBM) diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: Whey protein concentrate (WPC) diet
Number of subjects: 9
Study: 35242595

Group type: EXPERIMENTAL
Intervention: Guided internet-based cognitive behavioral therapy (ICBT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 31
Study: 32176193

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 160
Study: 35412873

Group type: EXPERIMENTAL
Intervention: Celecoxib (6 mg/kg/dose, twice daily for up to 10 days)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 34910312

Group type: EXPERIMENTAL
Intervention: Odiparcil 250 mg twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Odiparcil 500 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32592897

Group type: EXPERIMENTAL
Intervention: Positive airway pressure (PAP) therapy during hospitalization, n = 75
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group receiving guideline-directed therapy for HF decompensation, n = 75
Number of subjects: 150
Study: 34935585

Group type: EXPERIMENTAL
Intervention: Anamnesis interview (experimental group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no anamnesis interview)
Number of subjects: 65
Study: 33429389

Group type: EXPERIMENTAL
Intervention: CD + T1DM
Number of subjects: 783

Group type: COMPARATOR
Intervention: CDo
Number of subjects: 783

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 783
Study: 32668476

Group type: EXPERIMENTAL
Intervention: VL10
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: VL30
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: VL50
Number of subjects: 45
Study: 33565676

Group type: EXPERIMENTAL
Intervention: Training and support for ACCHS staff
Number of subjects: 70419

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 70419
Study: 32517389

Group type: EXPERIMENTAL
Intervention: USG-ICPB (intermediate cervical plexus block)
Number of subjects: 98

Group type: COMPARATOR
Intervention: USG-SCPB (superficial cervical plexus block)
Number of subjects: 98
Study: 35853675

Group type: EXPERIMENTAL
Intervention: 80 mg IXE every 4 weeks or 2 weeks
Number of subjects: 932
Study: 33455408

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 0
Study: 36364802

Group type: EXPERIMENTAL
Intervention: Mulberry leaf powder with 12 mg of 1-deoxynojirimycin (DNJ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mulberry leaf powder extract
Number of subjects: 0
Study: 34731076

Group type: EXPERIMENTAL
Intervention: Self‐affirmation Implementation Intention
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Kindness Questionnaire
Number of subjects: 454

Group type: COMPARATOR
Intervention: Control
Number of subjects: 454
Study: 33259721

Group type: EXPERIMENTAL
Intervention: Lavender oil scent during heel lancing
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no lavender oil scent) during heel lancing
Number of subjects: 61
Study: 33285343

Group type: EXPERIMENTAL
Intervention: Intralesional meglumine antimoniate (IL‐MA) administered via subcutaneous injection at approximately 1 mL/cm2 of lesion area once weekly for 1–8 weeks.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Intravenous meglumine antimoniate (IV‐MA) administered via intravenous injections at a dosage of 10–20 mg Sb5+/kg/day for 20 days.
Number of subjects: 240
Study: 36282755

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) for 1 hour daily from birth until postnatal week 5
Number of subjects: 116

Group type: COMPARATOR
Intervention: Care-as-usual condition
Number of subjects: 116
Study: 34757654

Group type: EXPERIMENTAL
Intervention: High fat yogurt condition
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low fat yogurt condition
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High fat/High fat yogurt condition
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low fat/Low fat yogurt condition
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High fat condition
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High fat and Low fat conditions
Number of subjects: 96
Study: 36322838

Group type: EXPERIMENTAL
Intervention: Once-weekly subcutaneous semaglutide (2.4 mg)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 34010748

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32237056

Group type: EXPERIMENTAL
Intervention: Forced‐air warming
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Mild intermittent exercise on the bed
Number of subjects: 51

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 51
Study: 33806189

Group type: EXPERIMENTAL
Intervention: Fixed prostheses supported by 2-4 zygomatic and 2-4 conventional implants
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fixed prostheses on four implants (all-on-four concept)
Number of subjects: 80
Study: 33599706

Group type: EXPERIMENTAL
Intervention: Prostate radiotherapy (RT) in addition to standard of care (androgen deprivation therapy with or without docetaxel)
Number of subjects: 1939

Group type: COMPARATOR
Intervention: Standard of care (androgen deprivation therapy with or without docetaxel)
Number of subjects: 1939
Study: 32316824

Group type: EXPERIMENTAL
Intervention: Resilience intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 92

Group type: COMPARATOR
Intervention: Follow-up
Number of subjects: 92
Study: 36150662

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for diverticulitis
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for complicated UTI
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for endocarditis
Number of subjects: 243
Study: 33710083

Group type: EXPERIMENTAL
Intervention: Peer support added to standard case management
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 166
Study: 33226894

Group type: EXPERIMENTAL
Intervention: Joy Luck Academy (JLA) intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 86
Study: 33859168

Group type: EXPERIMENTAL
Intervention: T-705
Number of subjects: 145

Group type: COMPARATOR
Intervention: Supportive care only (Control)
Number of subjects: 145
Study: 32014119

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus cetuximab
Number of subjects: 257

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 257
Study: 36176739

Group type: EXPERIMENTAL
Intervention: Yupingfeng granules combined with conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 0
Study: 36209759

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice a day for 7 days
Number of subjects: 300

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice a day for 14 days
Number of subjects: 300
Study: 34463610

Group type: EXPERIMENTAL
Intervention: FP‐SAL (fluticasone propionate plus salmeterol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salmeterol
Number of subjects: 0
Study: 37391596

Group type: EXPERIMENTAL
Intervention: Telemonitoring in chronic heart failure
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Data management and transmission of routine data
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Close communication with SHI funds and intensive data checking
Number of subjects: 1450
Study: 34213584

Group type: EXPERIMENTAL
Intervention: EcN® 320 mg, twice daily for 4 weeks and then once daily for 8 weeks (Group B)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Levofloxacin® 500 mg once daily for 4 weeks (Group A)
Number of subjects: 110
Study: 32371502

Group type: EXPERIMENTAL
Intervention: Intensive patient educational programme
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard written and verbal instructions (Control)
Number of subjects: 300
Study: 34750297

Group type: EXPERIMENTAL
Intervention: AHEU (in‐utero combination antiretroviral treatment)
Number of subjects: 943

Group type: EXPERIMENTAL
Intervention: AHEU (Zidovudine alone)
Number of subjects: 943

Group type: COMPARATOR
Intervention: HUU (control group)
Number of subjects: 943

Group type: EXPERIMENTAL
Intervention: AHEU (in‐utero exposures to ZDV)
Number of subjects: 943
Study: 34769736

Group type: EXPERIMENTAL
Intervention: Ergonomic training (theoretical and practical)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (received training at the end of the study)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intervention group (received ergonomic training)
Number of subjects: 60
Study: 32937032

Group type: EXPERIMENTAL
Intervention: Psychotropic medication use
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 873

Group type: COMPARATOR
Intervention: Adjustment disorders
Number of subjects: 873
Study: 32672653

Group type: EXPERIMENTAL
Intervention: Laser Peripheral Iridotomy (LPI)
Number of subjects: 455
Study: 36441137

Group type: EXPERIMENTAL
Intervention: CoronaVac (Lot 1)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: CoronaVac (Lot 2)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: CoronaVac (Lot 3)
Number of subjects: 1080
Study: 34837974

Group type: EXPERIMENTAL
Intervention: Community-based intervention (CBI)
Number of subjects: 3927

Group type: COMPARATOR
Intervention: Control
Number of subjects: 3927
Study: 36158805

Group type: EXPERIMENTAL
Intervention: Physician led enteral feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protocol‐based feeding group
Number of subjects: 0
Study: 32282492

Group type: EXPERIMENTAL
Intervention: Magic Empowerment Program (3 workshops on 3 successive days, followed by weekly phone calls for 8 weeks)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Magic Empowerment Program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 84
Study: 34969608

Group type: EXPERIMENTAL
Intervention: Zataria‐Trachyspermum (ZT) capsule
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: COMPARATOR
Intervention: Mebeverine capsule
Number of subjects: 150
Study: 32386810

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 785

Group type: COMPARATOR
Intervention: Phacoemulsification cataract surgery (PCS)
Number of subjects: 785
Study: 33926535

Group type: EXPERIMENTAL
Intervention: Specialist palliative care intervention
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 236
Study: 34213586

Group type: EXPERIMENTAL
Intervention: Knee Control high-dose group (≥2 sessions)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Knee Control low-dose group (<1 session)
Number of subjects: 301
Study: 34550413

Group type: EXPERIMENTAL
Intervention: Teaching unit for primary and secondary prevention of unplanned pregnancies
Number of subjects: 1855
Study: 35411460

Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Laser-BLI
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: LED-BLI
Number of subjects: 230
Study: 33666156

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 29

Group type: COMPARATOR
Intervention: TNFi
Number of subjects: 29
Study: 34032758

Group type: EXPERIMENTAL
Intervention: Patient Engagement and Medication Safety Management (PE‐MSM) program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Medication safety education alone
Number of subjects: 120
Study: 35797618

Group type: EXPERIMENTAL
Intervention: Transanal irrigation (TAI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conservative treatment (control)
Number of subjects: 45
Study: 34620531

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1620
Study: 32453647

Group type: EXPERIMENTAL
Intervention: Mealtime ultra-rapid lispro (URLi)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Postmeal ultra-rapid lispro (URLi)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Mealtime lispro
Number of subjects: 269
Study: 36145214

Group type: EXPERIMENTAL
Intervention: Course for patients and nurses (CPN group)
Number of subjects: 119

Group type: COMPARATOR
Intervention: No course for patients and nurses (non-C group)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Course for nurses (CN group)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Course for patients (CP group)
Number of subjects: 119
Study: 33686520

Group type: EXPERIMENTAL
Intervention: Coping Skills Training (CST)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 31
Study: 32249651

Group type: EXPERIMENTAL
Intervention: Monique Burr Foundation's Child Safety Matters curriculum
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 1176
Study: 32276883

Group type: EXPERIMENTAL
Intervention: Alfaxalone at 3.5 mg kgâ€“1
Number of subjects: 66

Group type: COMPARATOR
Intervention: Alfaxalone 2 mg kgâ€“1 and medetomidine 40 Î¼g kgâ€“1, reversed with atipamezole at 0.16 mg kgâ€“1
Number of subjects: 66
Study: 35623880

Group type: EXPERIMENTAL
Intervention: High-calcium breakfast from calcium citrate (∼770 mg/d)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-calcium breakfast from skim milk (∼770 mg/d)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low calcium breakfast (control, ∼70 mg of calcium/d)
Number of subjects: 35
Study: 34858506

Group type: EXPERIMENTAL
Intervention: Body Acupuncture (BA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture + Cupping (CA)
Number of subjects: 60
Study: 33268715

Group type: EXPERIMENTAL
Intervention: Ice cream with azithromycin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Yogurt with carbocysteine
Number of subjects: 16
Study: 36108265

Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME)
Number of subjects: 34
Study: 34774348

Group type: EXPERIMENTAL
Intervention: Atropine 0.01% eye drops (1 drop/day for 2 years)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 339
Study: 32042166

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study: 35505362

Group type: EXPERIMENTAL
Intervention: WHO‐EMRO School Mental Health Manual based Intervention
Number of subjects: 231

Group type: COMPARATOR
Intervention: Wait list delayed intervention control group
Number of subjects: 231
Study: 32506456

Group type: EXPERIMENTAL
Intervention: Interventional treatment (transjugular thrombus fragmentation, local thrombolysis with or without stent implantation)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 65
Study: 34501630

Group type: EXPERIMENTAL
Intervention: Exposure to varied neighborhood contexts (including neighborhood socioeconomic status, older housing stock, residential instability, and prevalence of neurological hazards in the ambient air)
Number of subjects: 590
Study: 34228102

Group type: EXPERIMENTAL
Intervention: IV zoledronic acid (ZA) 0.05 mg/kg
Number of subjects: 34

Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: IV zoledronic acid (ZA)
Number of subjects: 34